Protective effect of cyanidin-3-O-β-D-glucopyranoside fraction from mulberry fruit pigment against oxidative damage in streptozotocin-induced diabetic rat bladder

Neurourology and Urodynamics

Volumn 32, Issue 5, 2013, Pages 493-499

  Ha, U Syn ^a   Bae, Woong Jin ^a   Kim, Su Jin ^a   Yoon, Byung Il ^a   Jang, Hoon ^a   Hong, Sung Hoo ^a   Lee, Ji Yeoul ^a   Hwang, Seung Yeon ^b   Kim, Sae Woong ^a  

^a The Catholic University of Korea College of Medicine   (South Korea)

^b Korea Bio Medical Science Institute   (South Korea)

Author keywords

cyaniding 3 O D glucopyranoside; diabetes mellitus; rats; urinary bladder

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; CYANIDIN 3 O BETA D GLUCOPYRANOSIDE; MULBERRY EXTRACT; NERVE GROWTH FACTOR; PROTECTIVE AGENT; PROTEIN BAD; PROTEIN KINASE B; STREPTOZOCIN; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; 8-OXO-7-HYDRODEOXYGUANOSINE; ANTHOCYANIN; ANTIOXIDANT; BAD PROTEIN, RAT; CYANIDIN-3-O-BETA-GLUCOPYRANOSIDE; DEOXYGUANOSINE; PLANT EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BLADDER CAPACITY; BLADDER DYSFUNCTION; BLADDER FUNCTION; COMPARATIVE STUDY; CONTROLLED STUDY; CYSTOMETRY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOBLOTTING; MALE; MULBERRY; NICK END LABELING; NONHUMAN; OXIDATIVE STRESS; PHOSPHORYLATION; RAT; STREPTOZOCIN DIABETES; WESTERN BLOTTING; ANALOGS AND DERIVATIVES; ANIMAL; BLADDER; CHEMICALLY INDUCED; CHEMISTRY; DIABETES MELLITUS, EXPERIMENTAL; DRUG EFFECTS; FRUIT; ISOLATION AND PURIFICATION; MEDICINAL PLANT; METABOLISM; MORUS; PATHOLOGY; PATHOPHYSIOLOGY; PHYTOTHERAPY; PRESSURE; SPRAGUE DAWLEY RAT; TIME; URODYNAMICS;

ANIMALS; ANTHOCYANINS; ANTIOXIDANTS; APOPTOSIS; BCL-ASSOCIATED DEATH PROTEIN; DEOXYGUANOSINE; DIABETES MELLITUS, EXPERIMENTAL; FRUIT; MALE; MORUS; NERVE GROWTH FACTOR; OXIDATIVE STRESS; PHOSPHORYLATION; PHYTOTHERAPY; PLANT EXTRACTS; PLANTS, MEDICINAL; PRESSURE; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, SPRAGUE-DAWLEY; STREPTOZOCIN; SUPEROXIDE DISMUTASE; TIME FACTORS; URINARY BLADDER; URODYNAMICS;

EID: 84879373729     PISSN: 07332467     EISSN: 15206777     Source Type: Journal    
DOI: 10.1002/nau.22334     Document Type: Article

References (39)

1. Brown JS, Wessells H, Chancellor MB, et al. Urologic complications of diabetes. Diabetes Care 2005; 28: 177-85. (Pubitemid 40095802)
2. Sasaki K, Yoshimura N, Chancellor MB,. Implications of diabetes mellitus in urology. Urol Clin North Am 2003; 30: 1-12. (Pubitemid 36158465)
3. Yoshimura N, Chancellor MB, Andersson KE, et al. Recent advances in understanding the biology of diabetes-associated bladder complications and novel therapy. BJU Int 2005; 95: 733-8. (Pubitemid 40547197)
4. Beshay E, Carrier S,. Oxidative stress plays a role in diabetes-induced bladder dysfunction in a rat model. Urology 2004; 64: 1062-7. (Pubitemid 39469546)
5. Kanika ND, Chang J, Tong Y, et al. Oxidative stress status accompanying diabetic bladder cystopathy results in the activation of protein degradation pathways. BJU Int 2011; 107: 1676-84.
6. Dugo P, Mondello L, Errante G, et al. Identification of anthocyanins in berries by narrow-bore high-performance liquid chromatography with electrospray ionization detection. J Agric Food Chem 2001; 49: 3987-92. (Pubitemid 32822727)
7. Mitcheva M, Astroug H, Drenska D, et al. Biochemical and morphological studies on the effects of anthocyans and vitamin E on carbon tetrachloride induced liver injury. Cell Mol Biol (Noisy-le-grand) 1993; 39: 443-8.
8. Seeram NP, Momin RA, Nair MG, et al. Cyclooxygenase inhibitory and antioxidant cyanidin glycosides in cherries and berries. Phytomedicine 2001; 8: 362-9. (Pubitemid 32983056)
9. Elisia I, Kitts DD,. Anthocyanins inhibit peroxyl radical-induced apoptosis in Caco-2 cells. Mol Cell Biochem 2008; 312: 139-45.
10. Min J, Yu SW, Baek SH, et al. Neuroprotective effect of cyanidin-3-O-glucoside anthocyanin in mice with focal cerebral ischemia. Neurosci Lett 2011; 500: 157-61.
11. Ha US, Koh JS, Kim HS, et al. Cyanidin-3-O-beta- D -glucopyranoside concentrated materials from mulberry fruit have a potency to protect erectile function by minimizing Oxidative stress in a rat model of diabetic erectile dysfunction. Urol Int 2012; 88: 470-6.
12. Apfel SC,. Neurotrophic factors diabetic peripheral neuropathy. Eur Neurol 1999; 41: 27-34. (Pubitemid 29099612)
13. Paro M, Prosdocimi M, Sima AA,. Gangliosides improve urinary bladder dysfunction in experimental diabetic autonomic neuropathy. Pharmacol Res 1990; 22: 125-6.
14. Tong Y, Cheng J,. Changes in bladder nerve-growth factor and p75 genetic expression in streptozotocin-induced diabetic rats. BJU Int 2005; 96: 1392-6. (Pubitemid 41743943)
15. Sasaki K, Chancellor MB, Phelan MW, et al. Diabetic cystopathy correlates with a long-term decrease in nerve growth factor levels in the bladder and lumbosacral dorsal root ganglia. J Urol 2002; 168: 1259-64.
16. Kim HB, Kim SL, Koh SH, et al. The development of natural pigment with mulberry fruit as a food additive. Korean J Crop Sci 2011; 56: 18-22.
17. Qutub AA, Popel AS,. Reactive oxygen species regulate hypoxia-inducible factor 1alpha differentially in cancer and ischemia. Mol Cell Biol 2008; 28: 5106-19.
18. Mertens-Talcott SU, Rios J, Jilma-Stohlawetz P, et al. Pharmacokinetics of anthocyanins and antioxidant effects after the consumption of anthocyanin-rich acai juice and pulp (Euterpe oleracea Mart.) in human healthy volunteers. J Agric Food Chem 2008; 56: 7796-802.
19. Wang Q, Xia M, Liu C, et al. Cyanidin-3-O-beta-glucoside inhibits iNOS and COX-2 expression by inducing liver X receptor alpha activation in THP-1 macrophages. Life Sci 2008; 83: 176-84.
20. Peixoto EB, Pessoa BS, Biswas SK, et al. Antioxidant SOD mimetic prevents NADPH oxidase-induced oxidative stress and renal damage in the early stage of experimental diabetes and hypertension. Am J Nephrol 2009; 29: 309-18.
21. Marte BM, Downward J,. PKB/Akt: Connecting phosphoinositide 3-kinase to cell survival and beyond. Trends Biochem Sci 1997; 22: 355-8.
22. Downward J,. PI 3-kinase, Akt and cell survival. Semin Cell Dev Biol 2004; 15: 177-82. (Pubitemid 38251646)
23. Matsui T, Rosenzweig A,. Convergent signal transduction pathways controlling cardiomyocyte survival and function: The role of PI 3-kinase and Akt. J Mol Cell Cardiol 2005; 38: 63-71. (Pubitemid 40038652)
24. Lim JH, Kim SS, Boo DH, et al. Protective effect of bromocriptine against BH4-induced Cath.a cell death involving up-regulation of antioxidant enzymes. Neurosci Lett 2009; 451: 185-9.
25. Povsic TJ, Kohout TA, Lefkowitz RJ,. Beta-arrestin1 mediates insulin-like growth factor 1 (IGF-1) activation of phosphatidylinositol 3-kinase (PI3K) and anti-apoptosis. J Biol Chem 2003; 278: 51334-9. (Pubitemid 38020372)
26. Wang B, Shravah J, Luo H, et al. Propofol protects against hydrogen peroxide-induced injury in cardiac H9c2 cells via Akt activation and Bcl-2 up-regulation. Biochem Biophys Res Commun 2009; 389: 105-11.
27. Kimura R, Okouchi M, Fujioka H, et al. Glucagon-like peptide-1 (GLP-1) protects against methylglyoxal-induced PC12 cell apoptosis through the PI3K/Akt/mTOR/GCLc/redox signaling pathway. Neuroscience 2009; 162: 1212-9.
28. Datta SR, Dudek H, Tao X, et al. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 1997; 91: 231-41. (Pubitemid 27456390)
29. Nechushtan A, Smith CL, Hsu YT, et al. Conformation of the Bax C-terminus regulates subcellular location and cell death. EMBO J 1999; 18: 2330-41. (Pubitemid 29213267)
30. Downward J,. How BAD phosphorylation is good for survival. Nat Cell Biol 1999; 1: E33-5.
31. Bjorling DE, Beckman M, Clayton MK, et al. Modulation of nerve growth factor in peripheral organs by estrogen and progesterone. Neuroscience 2002; 110: 155-67. (Pubitemid 34214767)
32. Ochodnicky P, Cruz CD, Yoshimura N, et al. Nerve growth factor in bladder dysfunction: Contributing factor, biomarker, and therapeutic target. Neurourol Urodyn 2011; 30: 1227-41.
33. Sasaki K, Chancellor MB, Goins WF, et al. Gene therapy using replication-defective herpes simplex virus vectors expressing nerve growth factor in a rat model of diabetic cystopathy. Diabetes 2004; 53: 2723-30. (Pubitemid 39299286)
34. Goins WF, Yoshimura N, Phelan MW, et al. Herpes simplex virus mediated nerve growth factor expression in bladder and afferent neurons: Potential treatment for diabetic bladder dysfunction. J Urol 2001; 165: 1748-54. (Pubitemid 32410302)
35. Liu G, Daneshgari F,. Temporal diabetes- and diuresis-induced remodeling of the urinary bladder in the rat. Am J Physiol Regul Integr Comp Physiol 2006; 291: R837-43. (Pubitemid 44352370)
36. Steers WD, Mackway AM, Ciambotti J, et al. Effects of streptozotocin-induced diabetes on bladder function in the rat. J Urol 1990; 143: 1032-6. (Pubitemid 20156129)
37. Li WJ, Oh SJ,. Diabetic cystopathy is associated with PARP/JNK/mitochondrial apoptotic pathway-mediated bladder apoptosis. Neurourol Urodyn 2010; 29: 1332-7.
38. Daneshgari F, Liu G, Imrey PB,. Time dependent changes in diabetic cystopathy in rats include compensated and decompensated bladder function. J Urol 2006; 176: 380-6. (Pubitemid 43815409)
39. Lamb K, Gebhart GF, Bielefeldt K,. Increased nerve growth factor expression triggers bladder overactivity. J Pain 2004; 5: 150-6. (Pubitemid 38879393)